KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $56.7 million.

  • Emergent BioSolutions' Shares Outstanding (Diluted Average) rose 197.84% to $56.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.7 million, marking a year-over-year increase of 197.84%. This contributed to the annual value of $53.0 million for FY2024, which is 351.56% up from last year.
  • Per Emergent BioSolutions' latest filing, its Shares Outstanding (Diluted Average) stood at $56.7 million for Q3 2025, which was up 197.84% from $56.7 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Shares Outstanding (Diluted Average) registered a high of $57.3 million during Q1 2025, and its lowest value of $50.1 million during Q4 2022.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $52.6 million (2024), whereas its average is $53.0 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first crashed by 755.06% in 2022, then soared by 977.01% in 2025.
  • Over the past 5 years, Emergent BioSolutions' Shares Outstanding (Diluted Average) (Quarter) stood at $54.1 million in 2021, then fell by 7.39% to $50.1 million in 2022, then increased by 2.2% to $51.2 million in 2023, then increased by 3.52% to $53.0 million in 2024, then rose by 6.98% to $56.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $56.7 million for Q3 2025, versus $56.7 million for Q2 2025 and $57.3 million for Q1 2025.